国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

美國Accumetrics  
Accumetrics 致力于通過(guò)提供業(yè)界領(lǐng)先且廣泛可用的快速評估血小板功能的診斷檢測方法，來(lái)促進(jìn)醫學(xué)界對血小板功能的了解，并提高對正在接受抗血小板治療的患者的護理質(zhì)量。

Accumetrics 的 VerifyNow System 是幫助醫生判定個(gè)體患者對多種抗血小板藥物反應的首個(gè)快速且易于使用的平臺。VerifyNow System 適用于各種主要的抗血小板藥，包括獲得 FDA 批準的阿司匹林產(chǎn)品、P2Y12 抑制劑（如 prasugrel (Effient) 和 clopidogrel (Plavix)）、以及 GP IIb/IIIa 抑制劑（如 ReoPro(R) 和 Integrilin(R)），提供了一種可以幫助醫生做出明智治療決定的寶貴工具。

Accumetrics is at the forefront of revolutionizing the way doctors manage the tens of millions of patients who take antiplatelet drugs to prevent heart attack, stroke and other potentially life-threatening cardiovascular events.

Accumetrics is a privately-held company based in San Diego, California. The company develops, manufactures, and markets the VerifyNow? System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies. The tests are fully automated and easy-to-use allowing physicians an accurate way to assess platelet response to optimize the effectiveness of antiplatelet therapies, and to guide treatment decisions in patients who may be at risk of a life threatening thrombosis event or bleeding complication.